|
HY-W111226-250mg
|
MedChemexpress LLC
|
Fmoc-His(3-Me)-OH [CAS 252049-16-4]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-W111226-50mg
|
MedChemexpress LLC
|
Fmoc-His(3-Me)-OH [CAS 252049-16-4]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-13682B-1mg
|
MedChemexpress LLC
|
MifaMu rtide (sodium) [CAS 90825-43-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-13682B-10mg
|
MedChemexpress LLC
|
MifaMu rtide (sodium) [CAS 90825-43-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-13682B-5mg
|
MedChemexpress LLC
|
MifaMu rtide (sodium) [CAS 90825-43-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-13682C-1mg
|
MedChemexpress LLC
|
MifaMu rtide (TFA)
|
|
COVID-19-immunoregulation
|
|
|
HY-13682C-10mg
|
MedChemexpress LLC
|
MifaMu rtide (TFA)
|
|
COVID-19-immunoregulation
|
|
|
HY-13682C-5mg
|
MedChemexpress LLC
|
MifaMu rtide (TFA)
|
|
COVID-19-immunoregulation
|
|
|
HY-13682-1mg
|
MedChemexpress LLC
|
MifaMu rtide [CAS 83461-56-7]
|
|
Cancer-programmed cell death
|
|
|
HY-13682-10mg
|
MedChemexpress LLC
|
MifaMu rtide [CAS 83461-56-7]
|
|
Cancer-programmed cell death
|
|
|
HY-13682-5mg
|
MedChemexpress LLC
|
MifaMu rtide [CAS 83461-56-7]
|
|
Cancer-programmed cell death
|
|
|
sc-410775
|
Santa Cruz Biotechnology
|
PE-1 CRISPR/Cas9 KO Plasmid [Human]
|
Human
|
|
|
|
sc-424178
|
Santa Cruz Biotechnology
|
PE-1 CRISPR/Cas9 KO Plasmid [Mouse]
|
Mouse
|
|
|
|
sc-410775-NIC-2
|
Santa Cruz Biotechnology
|
PE-1 Double Nickase Plasmid [Human 2]
|
Human
|
|
|
|
sc-410775-NIC
|
Santa Cruz Biotechnology
|
PE-1 Double Nickase Plasmid [Human]
|
Human
|
|
|
|
sc-424178-NIC-2
|
Santa Cruz Biotechnology
|
PE-1 Double Nickase Plasmid [Mouse 2]
|
Mouse
|
|
|
|
sc-424178-NIC
|
Santa Cruz Biotechnology
|
PE-1 Double Nickase Plasmid [Mouse]
|
Mouse
|
|
|
